<DOC>
	<DOCNO>NCT01491568</DOCNO>
	<brief_summary>The purpose study evaluate feasibility use investigational implant ( rhBMP-2/CRM CD HORIZON® Spinal System ) method facilitate posterolateral lumbar spinal fusion two adjacent treatment level patient symptomatic degenerative disc disease .</brief_summary>
	<brief_title>rhBMP-2/CRM/CD HORIZON® Spinal System Pilot Study ( 2-Level )</brief_title>
	<detailed_description />
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>1 . Has degenerative disc disease two adjacent lumbar level note back pain discogenic origin , without leg pain , degeneration disc confirm patient history radiographic study include one following : instability ; osteophyte formation ; decrease disc height ; thicken ligamentous tissue ; disc degeneration herniation ; and/or facet joint degeneration . 2 . Has preoperative Oswestry score &gt; = 30 . 3 . Has great Grade 1 spondylolisthesis utilize Meyerding 's Classification ( Meyerding , HW , 1932 ) either treatment level . 4 . Requires fusion two adjacent lumbar level L1 S1 . 5 . Is least 18 year age , inclusive , time surgery . 6 . Has respond nonoperative treatment ( e.g. , bed rest , physical therapy , medication , spinal injection , manipulation , and/or TENS ) period 6 month . 7 . If female childbearing potential , patient nonpregnant nonnursing agree become pregnant 1 year follow surgery . 8 . Is willing able comply study plan sign Patient Informed Consent Form . 1 . Has primary diagnosis spinal disorder degenerative disc disease Grade 1 less spondylolisthesis involve level . 2 . Has previous spinal fusion surgical procedure ( ) involve level . 3 . Requires spinal fusion two lumbar level . 4 . Has condition require postoperative medication interfere fusion , steroid prolong use nonsteroidal antiinflammatory drug , exclude routine perioperative nonsteroidal antiinflammatory drug . This include low dose aspirin prophylactic anticoagulation . 5 . Has previously diagnose osteopenia , osteomalacia , osteoporosis , follow may associate diagnosis osteoporosis . ( If `` Yes '' criterion , dual xray absorptiometry [ DEXA ] scan require determine eligibility . ) Previously diagnose osteopenia , osteomalacia , osteoporosis . Postmenopausal nonblack female 60 year age weigh less 140 pound . Postmenopausal female sustain nontraumatic hip , spine , wrist fracture . Male age 70 . Male age 60 sustain nontraumatic hip spine fracture . If level bone mineral density ( BMD ) T score 3.5 low ( i.e. , 3.6 , 3.7 , etc . ) T score 2.5 low ( i.e. , 2.6 , 2.7 , etc . ) vertebral crush fracture , patient exclude study . 6 . Has presence active malignancy prior history malignancy ( except basal cell carcinoma skin ) . 7 . Has overt active bacterial infection , either local systemic . 8 . Has document titanium alloy allergy intolerance . 9 . Is mentally incompetent . If questionable , obtain psychiatric consult . 10 . Has Waddell Signs Inorganic Behavior Score 3 great . 11 . Is prisoner . 12 . Is alcohol and/or drug abuser define currently undergo treatment alcohol and/or drug abuse . 13 . Has receive drug may interfere bone metabolism within two week prior plan date spinal fusion surgery ( e.g. , steroids methotrexate ) . 14 . Has history autoimmune disease . 15 . Has history exposure injectable collagen silicone implant . 16 . Has history hypersensitivity protein pharmaceutical ( monoclonal antibody gamma globulin ) collagen . 17 . Has receive treatment investigational therapy within 28 day prior implantation surgery treatment plan 16 week follow rhBMP2/CRM implantation . 18 . Has receive previous exposure any/all BMPs either human animal extraction . 19 . Has history allergy bovine product history anaphylaxis . 20 . Has history endocrine metabolic disorder know affect osteogenesis ( e.g. , Paget 's disease , renal osteodystrophy , EhlersDalons syndrome , osteogenesis imperfecta ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>symptomatic degenerative disc disease two level</keyword>
</DOC>